Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cerulean Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

01 Aug 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Cerulean Pharma Inc (CERU-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

04 Aug 2015 Thomson Reuters Stock Report 11 $25.00

ValuEngine Rating and Forecast Report for CERU

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

03 Aug 2015 ValuEngine, Inc. 10 $25.00

ValuEngine Industry Report for Medical-Drugs(CERU)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

30 Jul 2015 ValuEngine, Inc. 10 $49.00

Wright Investors Service Comprehensive Report for Cerulean Pharma Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

27 Jul 2015 Wright Reports 50 $75.00

ValuEngine Industry Report for Medical-drugs(CERU)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

23 Jul 2015 ValuEngine, Inc. 10 $49.00

Cerulean Pharma, Inc. (CERU) - Financial Analysis Review

Cerulean Pharma, Inc. (CERU) - Financial Analysis Review Summary Cerulean Pharma, Inc. (Cerulean) formerly Tempo Pharma...

02 Jul 2015 GlobalData 39 $125.00

US MARKET ANALYSIS AND FORECAST. 70 PAGE REPORT PUBLISH QUARTERLY. IN EACH REPORT YOU WILL FIND 12-MONTHS FORECASTS ANALYSIS TARGET PRICE VALUATION RATINGS AND CREUDE OIL DEPENDENCE FOR 7396 US STOCKS.

29 Jun 2015 Pechala's Reports 83 $1,000.00

CERU.OQ - Event Transcript of Cerulean Pharma Inc conference call, Jun. 23, 2015 / 1:00PM ET

Edited Event Transcript of CERU.OQ conference call, Jun. 23, 2015 / 1:00PM ET New York, Jun 30, 2015 (Thomson StreetEve...

23 Jun 2015 Thomson Reuters StreetEvents 9 $75.00

CERULEAN - ENTERING A NEWSFLOW-RICH PERIOD

Cerulean looks well positioned to progress its ripening pipeline after a recent successful share offer and the receipt of FDA...

11 May 2015 Edison Investment Research 2 $10.00